Employees: 1-10
Investment Stage: Seed; Series A; Series B
Portfolio 30
Date | Name | Website | Total Raised | Location |
10.03.2024 | vTv Therap... | vtvtherape... | - | United Sta... |
10.03.2024 | Sana Biote... | sana.com | $2.79B | United Sta... |
10.05.2023 | DiogenX | diogenx.co... | $35.2M | France, Pr... |
02.08.2022 | Egle Thera... | egle-tx.co... | - | France, Il... |
13.08.2021 | GentiBio | gentibio.c... | $177M | United Sta... |
21.07.2021 | Abata Ther... | abatatx.co... | $95M | United Sta... |
16.07.2021 | Kriya Ther... | kriyathera... | $370M | United Sta... |
05.09.2019 | Veralox Th... | veraloxtx.... | $5.4M | - |
- | GluSense M... | glusenseme... | - | - |
- | Pandion Th... | pandiontx.... | $138M | United Sta... |
Show more
Persons 5
Date | First Name | Last Name | Title | Location | |||
- | Clay | Rowland | Associate | linkedin.c... | - | c******d@t... | - |
- | Nandan | Padukone | - | linkedin.c... | - | N*******e@... | - |
- | Katie | Ellias | Managing D... | linkedin.c... | - | k*****s@t1... | - |
- | Yury | Kukushkin | - | linkedin.c... | - | y********n... | - |
- | William | Orent | Associate | linkedin.c... | - | w****t@t1d... | - |
Mentions in press and media 18
Date | Title | Description | Source |
28.02.2024 | vTv Therapeutics Announces $51 Million Private Placement fro... | - | globenewsw... |
24.10.2023 | Former Novo Nordisk Executive, Dr. Todd Hobbs, joins Diasome... | Dr. Todd Hobbs, Former North American Chief Medical Officer at Novo Nordisk, to Guide Diasome's HDV ... | einpresswi... |
11.05.2023 | Biotech startup DiogenX secures €27.5M to develop therapeuti... | Marseille-based DiogenX, a preclinical-stage biotech company specialising in the development of panc... | siliconcan... |
09.11.2020 | Protomer Gets Boost to Develop Glucose Responsive Insulin | Protomer Technologies Inc., a Pasadena-based biopharmaceutical startup, closed a second round of fun... | dot.la/glu... |
09.11.2020 | Pasadena Biopharma Startup Protomer Gets an Investment Boost | Protomer Technologies Inc., a Pasadena-based biopharmaceutical startup, closed a second round of fun... | dot.la/glu... |
05.09.2019 | Veralox Therapeutics Raises $5.4 Million in Seed Funding Co-... | Funding to Advance Development of Drug Candidates Targeting Heparin-Induced Thrombocytopenia and Typ... | momentum.u... |
05.09.2019 | Veralox Therapeutics Raises $5.4 Million in Seed Funding Co-... | FREDERICK, Md.--(BUSINESS WIRE)--Veralox Therapeutics, a preclinical stage company focused on accele... | citybizlis... |
04.10.2018 | Precision medicine needs a business mindset in order to flou... | Precision medicine, also known as personalized medicine, has the potential to transform how we treat... | statnews.c... |
18.07.2018 | JDRF T1D Fund Appoints Ellias as Managing Director | The JDRF T1D Fund, a venture philanthropy fund focused on accelerating life-changing solutions to tr... | citybizlis... |
18.07.2018 | JDRF T1D Fund Appoints Ellias as Managing Director | The JDRF T1D Fund, a venture philanthropy fund focused on accelerating life-changing solutions to tr... | archive.ci... |
Show more